Psychosocial Intervention Ups Adherence to Antidepressants

Share this content:
Psychosocial Intervention Ups Adherence to Antidepressants
Psychosocial Intervention Ups Adherence to Antidepressants

THURSDAY, Sept. 28, 2017 (HealthDay News) -- A psychosocial intervention can improve early adherence to antidepressants among middle-aged and older adults, according to a study published online Sept. 27 in JAMA Psychiatry.

Jo Anne Sirey, Ph.D., from Weill Cornell Medicine in White Plains, New York, and colleagues conducted a clinical effectiveness study involving patients (aged ≥55 years) who received newly initiated depression treatment by their primary care physician. Participants were recruited within 10 days of their prescription and were randomly assigned to the intervention (Treatment Initiation and Participation Program [TIP]; 115 participants), which included three 30-minute contacts scheduled during a six-week period just after prescription of the antidepressant, or treatment as usual (116 participants). Participants in the TIP group identified and addressed barriers to adherence before developing a personalized adherence strategy.

The researchers found that patients in the TIP group were more likely to be adherent at six weeks (odds ratio, 5.54) and at both six and 12 weeks (odds ratio, 3.27). A significant, 24.9 percent, earlier reduction in depressive symptoms was seen for participants in the TIP group. Participants who were 80 percent adherent at weeks six and 12 in both groups had a 15 percent greater improvement in depressive symptoms over the course of treatment relative to baseline (P = 0.051).

"The Treatment Initiation and Participation Program is an effective intervention to improve early adherence to pharmacotherapy," the authors write. "Improved adherence can promote improvement in depression."

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Doctors Urged to Speak With Patients About Firearms

Doctors Urged to Speak With Patients About Firearms

Making a public commitment is encouraged as a positive action that physicians can take

Machine Learning Model Predicts Risk of Upgrade to Breast CA

Machine Learning Model Predicts Risk of Upgrade to ...

Model can predict risk of upgrade of high-risk breast lesions to cancer using traditional, text features

Glycemic Control Up With Oral Semaglutide in Type 2 Diabetes

Glycemic Control Up With Oral Semaglutide in Type ...

Phase 3 studies next to assess longer-term/clinical outcomes, safety

is free, fast, and customized just for you!

Already a member?

Sign In Now »